当前位置: X-MOL 学术J. Hum. Genet. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The third case of TNFRSF11A -associated dysosteosclerosis with a mutation producing elongating proteins
Journal of Human Genetics ( IF 3.5 ) Pub Date : 2020-10-09 , DOI: 10.1038/s10038-020-00831-8
Jing-Yi Xue 1, 2 , Zheng Wang 1, 3 , Sarah F Smithson 4, 5 , Christine P Burren 4, 6 , Naomichi Matsumoto 2 , Gen Nishimura 1 , Shiro Ikegawa 1 , Long Guo 1
Affiliation  

Dysosteosclerosis (DOS) is a distinct form of sclerosing bone disease characterized by platyspondyly and progressive osteosclerosis. DOS is genetically heterogeneous. Three causal genes, SLC29A3, CSF1R, and TNFRSF11A are reported. TNFRSF11A-associated DOS has been identified in two patients; however, TNFRSF11A is also a causal gene for osteopetrosis, autosomal recessive 7 (OP-AR7). Whole-exome sequencing in a patient with sclerosing bone disease identified novel compound heterozygous variants (c.414_427 + 7del, c.1664del) in TNFRSF11A. We examined the impact of the two variants on five splicing isoforms of TNFRSF11A by RT-PCR. We found that c.1664del resulted in elongated proteins (p.S555Cfs*121, etc.), while c.414_427 + 7del generated two aberrant splicing products (p.A139Wfs*19 and p.E132Dfs*19) that lead to nonsense mediated mRNA decay (NMD). In the previous two cases of TNFRSF11A-associated DOS, their mutations produced truncated TNFRSF11A protein isoforms. The mutations in all three cases thus contrast with TNFRSF11A mutations reported in OP-AR7, which does not generated truncated or elongated TNFRSF11A proteins. Thus, we identified the third case of TNFRSF11A-associated DOS and reinforced the genotype–phenotype correlation that aberrant protein-producing TNFRSF11A mutations cause DOS.



中文翻译:

第三例 TNFRSF11A 相关性骨硬化,具有产生伸长蛋白的突变

Dysosteosclerosis (DOS) 是一种不同形式的硬化性骨病,其特征是扁平脊柱和进行性骨硬化。DOS 在基因上是异质的。报告了三个因果基因,SLC29A3、CSF1RTNFRSF11A。已在两名患者中鉴定出TNFRSF11A相关的 DOS;然而,TNFRSF11A也是骨硬化症的致病基因,常染色体隐性遗传 7 (OP-AR7)。全基因组测序中,在硬化性骨病鉴定的新型复合杂合的变体(c.414_427 + 7del,c.1664del)的患者TNFRSF11A。我们检查了两种变体对TNFRSF11A 的五种剪接同种型的影响通过 RT-PCR。我们发现 c.1664del 导致蛋白质延长(p.S555Cfs*121 等),而 c.414_427 + 7del 产生两种异常剪接产物(p.A139Wfs*19 和 p.E132Dfs*19),导致无意义介导mRNA 衰减 (NMD)。在前两个与TNFRSF11A相关的 DOS病例中,它们的突变产生了截短的 TNFRSF11A 蛋白同种型。因此,所有三个病例中的突变与 OP-AR7 中报道的TNFRSF11A突变形成对比,后者不产生截短或延长的 TNFRSF11A 蛋白。因此,我们确定了第三例与TNFRSF11A相关的 DOS,并加强了基因型-表型相关性,即产生异常蛋白质的TNFRSF11A突变导致 DOS。

更新日期:2020-10-11
down
wechat
bug